DK76688A - Vaccine indeholdende f-proteinet fra aids-virus - Google Patents

Vaccine indeholdende f-proteinet fra aids-virus

Info

Publication number
DK76688A
DK76688A DK076688A DK76688A DK76688A DK 76688 A DK76688 A DK 76688A DK 076688 A DK076688 A DK 076688A DK 76688 A DK76688 A DK 76688A DK 76688 A DK76688 A DK 76688A
Authority
DK
Denmark
Prior art keywords
protein
vaccine containing
aids virus
aids
virus
Prior art date
Application number
DK076688A
Other languages
English (en)
Other versions
DK76688D0 (da
Inventor
Marie-Paule Kieny
Guy Bruno
Jean-Pierre Lecocq
Luc Montagnier
Original Assignee
Transgene Sa
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa, Pasteur Institut filed Critical Transgene Sa
Publication of DK76688A publication Critical patent/DK76688A/da
Publication of DK76688D0 publication Critical patent/DK76688D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK076688A 1986-06-16 1988-02-15 Vaccine indeholdende f-proteinet fra aids-virus DK76688D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608698A FR2600079B1 (fr) 1986-06-16 1986-06-16 Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
PCT/FR1987/000219 WO1987007642A1 (fr) 1986-06-16 1987-06-15 Vaccin, contenant la proteine f du virus du sida

Publications (2)

Publication Number Publication Date
DK76688A true DK76688A (da) 1988-02-15
DK76688D0 DK76688D0 (da) 1988-02-15

Family

ID=9336386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK076688A DK76688D0 (da) 1986-06-16 1988-02-15 Vaccine indeholdende f-proteinet fra aids-virus

Country Status (11)

Country Link
EP (1) EP0253693B1 (da)
JP (1) JPH01500962A (da)
KR (1) KR880701285A (da)
AT (1) ATE103980T1 (da)
AU (1) AU614934B2 (da)
DE (1) DE3789525T2 (da)
DK (1) DK76688D0 (da)
ES (1) ES2062990T3 (da)
FR (1) FR2600079B1 (da)
PT (1) PT85093B (da)
WO (1) WO1987007642A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615623B1 (fr) * 1987-05-22 1992-06-19 Transgene Sa Test de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique, vaccins et serotherapies
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
JPH03503639A (ja) * 1988-04-01 1991-08-15 アンステイテユ・パストウール レトロウイルスｈｉｖのペプチドｐｆ１０〜ｐｆ１９、該ペプチドの合成方法、特に診断用としてのその使用
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
FR2629460B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf16 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation pour le diagnostic
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
EP0485611B1 (en) * 1990-05-28 1999-03-17 The Research Foundation For Microbial Diseases Of Osaka University Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
FR2766091A1 (fr) * 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee

Also Published As

Publication number Publication date
AU7514087A (en) 1988-01-11
JPH01500962A (ja) 1989-04-06
ES2062990T3 (es) 1995-01-01
PT85093A (fr) 1987-07-01
PT85093B (pt) 1990-03-30
ATE103980T1 (de) 1994-04-15
DK76688D0 (da) 1988-02-15
FR2600079A1 (fr) 1987-12-18
EP0253693A1 (fr) 1988-01-20
DE3789525D1 (de) 1994-05-11
DE3789525T2 (de) 1994-08-25
KR880701285A (ko) 1988-07-26
FR2600079B1 (fr) 1989-10-20
AU614934B2 (en) 1991-09-19
EP0253693B1 (fr) 1994-04-06
WO1987007642A1 (fr) 1987-12-17

Similar Documents

Publication Publication Date Title
ATE141946T1 (de) Hiv-2-virusvarianten
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
EP0256092A4 (en) WEAKENED HERPESVIRUSES, HERPESVIRUSES THAT CONTAIN A FOREIGN DNA ENCODING AMINO ACID SEQUENCES, AND VACCINALS THAT CONTAIN THEM.
DE3789973D1 (de) Zahnimplantat zur Befestigung von Zahnersatz-Suprakonstruktionen.
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
DK641787A (da) Virusvektor, der koder for et glycoprotein fra det virus, der er ansvarligt for aids, vaccine, der omfatter virusvektoren eller glycoproteinet, samt antistof mod glycoproteinet
DE3776999D1 (de) Mittel zur vorbeugung gegen pflanzenviruskrankheiten.
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DK498387A (da) Virus-dna-sekvens
ATE124991T1 (de) Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine.
DK631387A (da) Virusvektor
FI872363A7 (fi) Bakteriosiinit ja niitä sisältävät koostumukset virusinfektioiden detektioon ja hoitoon.
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
DE68925356D1 (de) Nicht-zurückmutierende RNA-Viren
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
ATE84070T1 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
RU92016478A (ru) Способ диагностики гепатита, способ лечения гепатита
ATE81454T1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
IT210946Z2 (it) Attacco ammortizzato per protesi dentaria.
NO900080L (no) Biologisk aktiv myseproteinblanding, en fremgangsmaate forfremstilling av den og anvendelse av blandingen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment